Open AccessCost-Effectiveness of Eszopiclone for the Treatment of Adults with Primary Chronic Insomnia
Author(s) -
Sonya J. Snedecor,
Marc Botteman,
Chris Bojke,
Kendyl Schaefer,
N Barry,
A. Simon Pickard
Publication year - 2009
Publication title -
sleep
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.222
H-Index - 207
eISSN - 1550-9109
pISSN - 0161-8105
DOI - 10.1093/sleep/32.6.817
Subject(s) - presenteeism , medicine , absenteeism , insomnia , placebo , cost effectiveness , quality adjusted life year , physical therapy , primary insomnia , indirect costs , randomized controlled trial , sleep disorder , psychiatry , psychology , alternative medicine , social psychology , risk analysis (engineering) , accounting , pathology , business
To assess the cost-effectiveness of treatment with eszopiclone for chronic primary insomnia in adults.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom